Why is Trident Texofab falling/rising?

As of 01-Sep, Trident Texofab Ltd's stock price is currently at Rs 251.30, reflecting a decrease of Rs 1.6 or 0.63%. Today, the stock reached a new 52-week high of Rs 259 but has since fallen after two consecutive days of gains. The stock opened with a gain of 2.41% but experienced significant volatility, touching a low of Rs 240, which represents a decline of 5.1%. Despite this, the stock has shown strong performance over the past year, with a remarkable return of 468.29%, and has consistently outperformed the BSE500 index over various time frames. The company has reported positive results for the last three consecutive quarters, with net sales growth of 24.20% and strong operating profit margins, which could support investor confidence despite the recent price drop.
In the broader market context, Trident Texofab's short-term performance has been notably better than the benchmark, as it has gained 4.75% over the past week while the Sensex has declined by 1.56%. This indicates that the stock is maintaining a strong position relative to the market, even amidst its current price decline. Additionally, the stock's liquidity appears healthy, with a significant increase in delivery volume, suggesting rising investor participation. Overall, while the stock is experiencing a slight decline today, its long-term performance and recent positive financial results may continue to attract investors despite short-term fluctuations.